Hisaomi Suzuki
Hisaomi Suzuki publishes mostly in Psychiatry and Mental health, Physiology and Molecular Biology, on topics such as Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research and Schizophrenia research and treatment.
- World rank
- #2,231,762 of 7,710,434 ranked researchers
- Rank in Japan
- #42,752 of 383,136
- Works
- 25
- Citations
- 660
- Citations per work
- 26.4
What does Hisaomi Suzuki research?
Hisaomi Suzuki's work is mostly in Medicine (54%), Neuroscience (13%), Biochemistry, Genetics and Molecular Biology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1353.6%
- Medicine1353.6%
- Life Sciences623.9%
- Everything else622.5%
- 1Psychiatry and Mental health28% of their works
- 2Physiology16% of their works
- 3Molecular Biology11% of their works
- 4Neurology10% of their works
- 5Cognitive Neuroscience7% of their works
- 6Cellular and Molecular Neuroscience6% of their works
Research topics
- Alzheimer's disease research and treatments
- Dementia and Cognitive Impairment Research
- Schizophrenia research and treatment
- Functional Brain Connectivity Studies
- Amyotrophic Lateral Sclerosis Research
- Prion Diseases and Protein Misfolding
- Phosphodiesterase function and regulation
- Neuroscience and Neuropharmacology Research
Which keywords describe Hisaomi Suzuki's research?
The keywords of their largest research topics: Neurodegeneration, Amyloid Hypothesis, Tau Pathology, Alzheimer's Disease, Mild Cognitive Impairment, Antipsychotic Drugs, Neurocognitive Deficits and Neurological Disorders.
- cAMP Signaling
- Prion Diseases
- Molecular Basis
- TDP-43
- Functional Connectivity
- Neurological Disorders
- Antipsychotic Drugs
- Alzheimer's Disease
- Amyloid Hypothesis
- Neurodegeneration
- Tau Pathology
- Mild Cognitive Impairment
- Neurocognitive Deficits
- FUS/TLS
- Resting-State fMRI
- Cyclic Nucleotide Phosphodiesterases
- Neurotransmission
- Synaptic Plasticity
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Neurodegeneration142 topics
- Amyloid Hypothesis111 topic
- Tau Pathology111 topic
- Alzheimer's Disease81 topic
- Mild Cognitive Impairment81 topic
- Antipsychotic Drugs61 topic
- Neurocognitive Deficits61 topic
- Neurological Disorders52 topics
- FUS/TLS31 topic
- Functional Connectivity31 topic
- Resting-State fMRI31 topic
- TDP-4331 topic
- Cyclic Nucleotide Phosphodiesterases21 topic
- Molecular Basis21 topic
- Neurotransmission21 topic
- Prion Diseases21 topic
- Synaptic Plasticity21 topic
- cAMP Signaling21 topic
Where does Hisaomi Suzuki work?
Hisaomi Suzuki's main affiliation in the publication record is National Hospital Organization, Japan.
How many publications and citations does Hisaomi Suzuki have?
OpenAlex counts 25 works and 660 citations for Hisaomi Suzuki, an h-index of 7, ranking #2,231,762 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hisaomi Suzuki. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.